GDLS to upgrade more Abrams for US Army
General Dynamics Land Systems (GDLS) has received a $714 million delivery order from the US Army to upgrade an additional 174 M1A1 Abrams main battle tanks to the M1A2 System Enhancement Package Version 3 (SEPv3) configuration, the company announced on 8 January.
The order is part of a contract signed in December 2017, under which the US Army can upgrade up to 435 M1A1 Abrams tanks to the M1A2 SEPv3 configuration. This order brings the total of M1A2 SEPv3 tanks ordered by the army in 2018 to 274.
The upgraded M1A2 SEPv3 configuration has improved communications and networking capabilities, additional electrical power from an auxiliary power unit, upgraded armour, an ammo data link to interface with advanced ammunition and reduced maintenance requirements.
Related Equipment in Defence Insight
More from Land Warfare
-
Australian Army advances with the implementation of countermining training
The branch entered this year in the second phase of the deployment of the FLAIM Sweeper system.
-
Need more flexibility in battle management system delivery?
Systematic’s newest solution, SitaWare BattleCloud, brings greater flexibility to combat information systems and C4ISR.
-
QinetiQ awarded contract for further work on lasers, future systems and energy weapons
Notable projects under the Weapons Sector Research Framework (WSRF) contract include the British Army determining the impact of a vehicle-mounted laser weapon on drones and testing a vehicle-mounted Radio Frequency Directed Energy Weapon (RFDEW).
-
Beretta discloses details of its proposal for the British Army’s Project Grayburn
The company is offering weapons and accessories produced by itself and by other Beretta Holding subsidiaries.
-
Europe’s next-generation tank crawls forward and adopts a proven process
The Franco-German Main Ground Combat System (MGCS) is ambitious and is using a procurement system which has had some success in the continent’s aircraft purchasing processes with a separate company established and subsystems identified.